Advances in screening of thalassaemia

Clin Chim Acta. 2022 Sep 1:534:176-184. doi: 10.1016/j.cca.2022.08.001. Epub 2022 Aug 3.

Abstract

Thalassaemia is a common hereditary haemolytic anaemia. Mild cases of this disease may be asymptomatic, while patients with severe thalassaemias require high-dose blood transfusions and regular iron removal to maintain life or haematopoietic stem cell transplantation to be cured, imposing an enormous familial and social burden. Therefore, early, timely, and accurate screening of patients is of great importance. In recent years, with the continuous development of thalassaemia screening technologies, the accuracy of thalassaemia screening has also improved significantly. This article reviews the current research on thalassaemia screening.

Keywords: DNA analysis; Haemoglobin analysis; Mass spectrometry; RBC indices; Screening method; Thalassaemia.

Publication types

  • Review

MeSH terms

  • Blood Transfusion
  • Humans
  • Mass Screening
  • Thalassemia* / diagnosis
  • Thalassemia* / genetics
  • beta-Thalassemia*